mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Последние новости
⚑ Сообщить о проблемеTech news from the best sources
Tech news from the best sources
The vaccine reportedly thwarted the cancer's return and spread.